MIRIAM CHESKY: Open Payments
NPI 1285882035 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 35 payments from 12 companies in 2025. Trend: 2023 $185 · 2024 $453 · 2025 $752
Food & beverage: $739Education: $13
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $198 |
| Novartis Pharmaceuticals Corporation | 9 | $149 |
| Galderma Laboratories, L.P. | 4 | $101 |
| UCB, Inc. | 3 | $83 |
| ABBVIE INC. | 3 | $60 |
| Organon LLC | 4 | $36 |
| Lilly USA, LLC | 1 | $27 |
| LEO Pharma Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
Products named: TREMFYA, COSENTYX, NEMLUVIO, Bimzelx, VTAMA, SKYRIZI, TALTZ, ADBRY.
Industry payments across PA — which companies pay providers there.
